Systemic vasculitides - Ophthalmological aspects of diagnosis;Ophthalmologische diagnostik bei systemischen vaskulitiden

Zeitschrift fur Rheumatologie

Volumn 60, Issue 4, 2001, Pages 226-242

  Nolle B ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Diagnostics; Overview; Symptoms; Vasculitis eye

Indexed keywords

ARTICLE; BEHCET DISEASE; CONJUNCTIVA DISEASE; CORNEA DISEASE; DIAGNOSTIC PROCEDURE; EYE DISEASE; EYE INFLAMMATION; EYELID DISEASE; GIANT CELL ARTERITIS; LACRIMAL DUCT; LENS DISEASE; OPTIC NERVE; ORBIT DISEASE; SCLERA DISEASE; SYSTEMIC VASCULITIS; TEAR FILM; WEGENER GRANULOMATOSIS;

DIAGNOSIS, DIFFERENTIAL; EYE DISEASES; HUMANS; PATIENT CARE TEAM; RHEUMATIC DISEASES; VASCULITIS;

EID: 0034853181     PISSN: 03401855     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003930170048     Document Type: Article

References (109)

1. Ocular presentation of polyarteritis nodosa. Clinical course and management with steroid and cytotoxic therapy
2. Severity of episcleritis and systemic disease association
3. Pseudotumor as the presenting sign of Wegener's granulomatosis in a child
4. Wegener's granuloma: A series of 265 British cases seen between 1975-1985
5. Peripheral corneal degeneration and occlusive vasculitis in Wegener's granulomatosis
6. Sjögren's syndrome: A critical review of clinical management
7. Diagnostic tests in the Sicca syndrome
8. Augenbeteiligung bei der Wegenerschen granulomatose
9. Orbital infarction syndrome
10. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes
11. Granulomatous sclerouveitis: Regression of ocular lesions with cyclophosphamide and prednisone
12. Ocular complications of Wegener's granulomatosis
13. Limited forms of angiitis and granulomatosis of Wegener's type
14. Pseudotumor of the orbit and limited Wegener's granulomatosis
15. Bilateral ocular ischemic syndrome secondary to giant cell arteritis
16. Diagnosis and management of systemic Wegener's granulomatosis presenting with anterior ocular inflammatory disease
17. Corneoscleral lesions in periarteritis nodosa and Wegener's granulomatosis
18. Association between active Wegener's granulomatosis and anticytoplasmic antibodies
19. Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre
20. Orbital involvement in Wegener granulomatosis: MR findings in 12 patients
21. Limited form of Wegener's granulomatosis: Eye involvement as a major sign
22. The ocular manifestation of lethal midline granuloma (Wegener's granulomatosis)
23. Wegenersche granulomatose: Okuläre manifestationen, diagnose und therapie
24. Ophthalmologische aspekte der Wegenerschen granulomatose
25. Neuer seromarker: Hilfe bei der differential-diagnostik unklarer skleraprozesse
26. Orbitale beteiligung bei Wegener'scher granulomatose
27. Orbital involvement in Wegener's granulomatosis
28. Wegener's granulomatosis
29. Wegener's granulomatosis: Studies in eighteen patients and a review of the literature
30. Wegener's granulomatosis: Prospective clinical and therapeutic experience with 85 patients for 21 years
31. Wegener's granulomatosis presenting with sclerokeratitis diagnosed by antineutrophil cytoplasmic autoantibodies (ANCA)
32. Current issues in the diagnosis and treatment of Sjögren's syndrome
33. Update in Sjögren syndrome
34. Pathology of 'pseudotumors' of the orbit: A review
35. Retinal specific antigens and immunopathogenic processes they provoke
36. Occlusion of the retinal artery in two cases of orbital granuloma
37. Wegener's granulomatosis: Pathology and review of the literature
38. Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients
39. Diagnostic tests in patients with symptoms of keratoconjunctivitis sicca
40. ANCA-assoziierte vaskulitiden (Wegener-Granulomatose, Churg-Strauss-Syndrom, Mikroskopische Polyangiitis) 2. Diagnostisches procedere
41. ANCA and associated diseases: Immunodiagnostic and pathogenetic aspects
42. ANCA-assoziierte vaskulitiden (Wegener-Granulomatose, Churg-Strauss-Syndrom, mikroskopische polyangiitis) 1. Systematik, pathogenese und klinik
43. New concepts in treatment protocols for severe systemic vasculitis
44. Protein-analytische methoden bei der diagnostik des Sicca-syndroms
45. Uveitis and anti-neutrophil cytoplasmic antibodies
46. Giant cell arteritis in the ocular ischemic syndrome
47. Ophthalmologic manifestations of rheumatic diseases
48. Surgical management of nasolacrimal duct obstruction in patients with Wegener's granulomatosis
49. Wegener's granulomatosis
50. The ocular manifestations of Wegener's granulomatosis. Fifteen years experience and review of the literature
51. Wegener granulomatosis: An analysis of 158 patients
52. Unilateral facial swelling and exophthalmos in a patient with polyarteritis nodosa
53. Nomenclature of systemic vasculitides: The proposal of an international consensus conference
54. Wegener's granulomatosis: Eyelid and conjunctival manifestations as the presenting feature in two individuals
55. Role of testing for anticytoplasmic autoantibodies in the differential diagnosis of scleritis and orbital pseudotumor
56. Diagnostic value and limitations of orbital biopsy in Wegener's granulomatosis
57. Choroidal involvement in systemic necrotizing vasculitis
58. Polyarteritis nodosa (PN) complicated with unilateral exophthalmos
59. Wegener's granulomatosis with destructive ocular manifestations
60. Wegener's granulomatosis presenting as dacryoadenitis
61. Evaluation and differential diagnosis of keratoconjunctivitis sicca
62. Wegener's granulomatosis: Histological documentation of common and uncommon manifestations in 216 patients
63. The bane of giant cell arteritis from an ophthalmological viewpoint
64. Vasculitic peripheral ulcerative keratitis
65. Magnetic resonance tomography and computerized tomography of Wegener's granulomatosis of the orbits
66. Anti-endothelial cell antibodies in systemic autoimmune diseases: Prevalence and clinical significance
67. Choroidopathy of systemic lupus erythematosus
68. Frequency of dry eye diagnostic test procedures used in various modes of ophthalmic practice
69. Immune privilege and immune regulation in the eye
70. The immune privilege of corneal allografts
71. ANCA in ocular inflammatory disorders
72. Augenmanifestationen bei systemischer vaskulitis
73. Wegener's granulomatosis presenting as orbital pseudotumor in children
74. Cortical blindness complicating Wegener's granulomatosis
75. The clinical and pathologic constellation of Wegener granulomatosis of the orbit
76. The diagnosis and management of dry eye: A twenty-five-year review
77. Disease relapse in patients with ocular manifestations of Wegener granulomatosis
78. Orbital involvement by Wegener's granulomatosis: Imaging findings
79. Ocular manifestations of patients with circulating antineutrophil cytoplasmic antibodies
80. Characterization of two corneal epithelium-derived antigens associated with vasculitis
81. Corneal epithelial-specific cytokeratin 3 is an autoantigen in Wegener's granulomatosis-associated peripheral ulcerative keratitis
82. Ocular involvement in the respiratory vasculitides
83. Necrotizing scleritis after ocular surgery: A clinicopathologic study
84. Immunoregulation, immune tolerance, autoimmunity, and immune privilege
85. Protracted uveitis as the initial manifestation of Wegener's granulomatosis
86. Leukocyte adhesion molecule expression in scleritis
87. Orbital lesions with granulomatous inflammation
88. Microscopic polyarteritis: Presentation, pathology and prognosis
89. Die Wegener'sche granulomatose aus ophthalmologischer sicht
90. Sicca syndrome in patients with Wegener's granulomatosis
91. Necrogranulomatous keratitis associated with Wegener's granulomatosis and rheumatoid arthritis
92. Fluorescein angiography in the diagnosis of giant cell arteritis
93. CT of the paranasal sinuses and orbits in patients with Wegener's granulomatosis
94. Pathogenesis of vasculitis syndromes
95. The spectrum of ocular involvement in patients with systemic lupus erythematosus without ocular symptoms
96. Diagnostic value of antineutrophil cytoplasmic antibodies in scleritis associated with Wegener's granulomatosis
97. Trimethoprim-sulfamethoxazole for scleritis associated with limited Wegener's granulomatosis: Use of histopathology and anti-neutrophil cytoplasmic antibody (ANCA) test
98. Ocular changes in limited forms of Wegener's granulomatosis
99. Ocular manifestations of Wegener's granulomatosis
100. Wegener's granulomatosis: Unusual indication for orbital decompression
101. Eosinophil and neutrophil degranulation in ophthalmic lesions of Wegener's granulomatosis
102. Florid xanthelasmata (yellow lids) in orbital Wegener's granulomatosis
103. Giant cell granuloma of the respiratory tract (Wegener's granulomatosis)
104. Churg-Strauss syndrome (allergic granulomatous angiitis). Neuro-ophthalmologic manifestations
105. Pseudotumor of the orbit as a presenting sign in Wegener's granulomatosis
106. Bilateral ocular ischemic syndrome in Takayasu disease
107. Autoantibodies against neutrophils and monocytes: Tool for diagnosis and marker of disease activity in Wegener's granulomatosis
108. The antineutrophil antibody in uveitis